10.08.09 | John Iwanicki comments on the Ariad Pharmaceuticals Inc. v. Eli Lilly & Co. case.

Mr. Iwanicki discusses the significance of the Federal Circuit rehearing the Ariad Pharmaceuticals v. Eli Lilly case and who should be watching this case, in an IP Law 360 article titled: Fed. Circ. To Weigh In On Written Description Rule.